Table 6 Summary of adverse events in the two groups
Groups | Nephrotoxicity (n, %) | Hepatotoxicity (n, %) | Peripheral neuropathy (n, %) | QTc prolongation (n,%) | Leukopenia (n, %) | hypokalemia (n, %) | Ototoxicity (n, %) | Others (n, %) | p value |
|---|---|---|---|---|---|---|---|---|---|
Bdq group (n=102) | 12 (11.8) | 9 (8.8) | 3 (3.0) | 3(3.0) | 2 (2.0) | 2 (2.0) | 2 (2.0) | 4 (3.9) | 0.21 |
Non-Bdq group (n=100) | 3 (3.0) | 2 (2.0) | 1 (1.0) | 2(2.0) | 2 (2.0) | 1 (1.0) | 8 (8.0) | 7 (7.0) |